The anxiety level of chemotherapy receiving patients and their caregivers and affecting factors

2016-04-11T22-25-23Z
Source: TAF Preventive Medicine Bulletin
Seyhan Çıtlık Sarıtaş, Zeliha Büyükbayram.
Aim: This study was performed to examine the anxiety level of chemotherapy receiving patients and their caregivers together with the affecting factors. Methods: The study was conducted as correlational and descriptive in Dicle University Oncology Hospital between June 2013 and July 2014. Chemotherapy patients over the age of 18 and caregivers in Dicle University Oncology Hospital constituted the population of the study. The sample was constituted by 250 chemotherapy receiving patients and 250 caregivers performed power analysis. Patient and caregiver identification form, State and Trait Anxiety Inventory, Edmonton Symptom Scale Diagnostics (Estonian) were used in the data collection. Descriptive statistics, paired t test, independent samples t test, Kruskal-Wallis Variance, Mann-Whitney U, Analysis of Variance (ANOVA) and Pearson Correlation test were used in the evaluation of data. Results: Among the patients who were included to the study, 97.6% were determined to be willing to continue to the treatment and 57.2% were determined to be women. It was found that average anxiety scores of women patients and the people who support the patient in coping with the disease were high and the difference was statistically significant (p


from Scope via xlomafota13 on Inoreader http://ift.tt/1VPvUfY
via IFTTT